AIM ImmunoTech (AIM) Institutional Ownership $0.26 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for AIM ImmunoTech (NYSE:AIM)CurrentInstitutional OwnershipPercentage12.02%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.52MNumber ofInstitutional Sellers(last 12 months)0 Get AIM Insider Trade Alerts Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AIM Institutional Buying and Selling by Quarter Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… AIM ImmunoTech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC4,078,000$1.52M0.0%N/A7.919% 11/16/2021Verition Fund Management LLC148,479$300K0.0%+37.5%0.310% 11/15/2021HighTower Advisors LLC41,095$82K0.0%-38.8%0.086% 10/28/2021WINTON GROUP Ltd82,564$167K0.0%+50.4%0.173% 10/19/2021 Arkadios Wealth Advisors21,597$43K0.0%N/A0.045% 8/17/2021Bridgeway Capital Management LLC246,000$529K0.0%-9.2%0.514% Get the Latest News and Ratings for AIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AIM ImmunoTech and its competitors with MarketBeat's FREE daily newsletter. 8/16/2021Schonfeld Strategic Advisors LLC23,100$49K0.0%-40.0%0.048% 8/16/2021State Street Corp160,413$345K0.0%N/A0.335% 8/13/2021Renaissance Technologies LLC152,848$329K0.0%-68.1%0.320% 8/13/2021Northern Trust Corp87,226$188K0.0%+28.8%0.182% 8/13/2021Vanguard Group Inc.1,993,156$4.29M0.0%+3.5%4.167% 8/12/2021XTX Topco Ltd29,269$63K0.0%N/A0.061% 8/12/2021Dimensional Fund Advisors LP139,160$299K0.0%N/A0.291% 8/10/2021WINTON GROUP Ltd54,894$118K0.0%N/A0.115% 6/4/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 5/19/2021Virtu Financial LLC29,484$67K0.0%-71.6%0.062% 5/18/2021Verition Fund Management LLC108,000$245K0.0%+80.0%0.226% 5/18/2021Morgan Stanley2,505,954$5.69M0.0%+150.9%5.240% 5/18/2021Citadel Advisors LLC103,283$234K0.0%N/A0.216% 5/17/2021Schonfeld Strategic Advisors LLC38,500$88K0.0%N/A0.081% 5/13/2021Renaissance Technologies LLC478,759$1.09M0.0%N/A1.001% 5/12/2021Geode Capital Management LLC351,750$798K0.0%+49.7%0.736% 5/11/2021Rockefeller Capital Management L.P.40,000$90K0.0%+100.0%0.084% 5/10/2021HighTower Advisors LLC63,095$143K0.0%N/A0.132% 5/10/2021GSA Capital Partners LLP74,790$170K0.0%+338.7%0.156% 5/7/2021BlackRock Inc.979,042$2.22M0.0%+91.7%2.047% 5/7/2021 Cambridge Investment Research Advisors Inc.46,679$106K0.0%+14.7%0.098% 5/4/2021Community Bank N.A.13,226$30K0.0%N/A0.028% 4/21/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 2/24/2021Virtu Financial LLC103,807$186K0.0%+250.7%0.255% 2/18/2021Verition Fund Management LLC60,000$107K0.0%+50.0%0.147% 2/5/2021BlackRock Inc.510,796$914K0.0%+1.6%1.255% 2/4/2021 Cambridge Investment Research Advisors Inc.40,679$73K0.0%+19.0%0.100% 2/4/2021GSA Capital Partners LLP17,047$31K0.0%-82.2%0.042% 12/11/2020Virtu Financial LLC29,604$64K0.0%-55.5%0.073% 11/13/2020Morgan Stanley805,415$1.73M0.0%+69.1%2.029% 11/12/2020JPMorgan Chase & Co.17,369$37K0.0%+868,350.0%0.044% 11/10/2020 Arkadios Wealth Advisors20,000$45K0.0%N/A0.050% 11/9/2020LPL Financial LLC20,500$44K0.0%N/A0.052% 11/6/2020BlackRock Inc.502,692$1.08M0.0%+5.7%1.267% I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.11/6/2020GSA Capital Partners LLP95,754$206K0.0%N/A0.241% 10/29/2020 Cambridge Investment Research Advisors Inc.34,179$73K0.0%N/A0.086% (Data available from 1/1/2016 forward) AIM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AIM shares? During the previous two years, the following institutional investors and hedge funds held shares of AIM ImmunoTech shares: Armistice Capital LLC ($1.52M).Learn more on AIM's institutional investors. What percentage of AIM ImmunoTech stock is owned by institutional investors? 12.02% of AIM ImmunoTech stock is owned by institutional investors. Learn more on AIM's institutional investor holdings. Which institutional investors have been buying AIM ImmunoTech stock? The following institutional investors have purchased AIM ImmunoTech stock in the last 24 months: Armistice Capital LLC ($4.08M). How much institutional buying is happening at AIM ImmunoTech? Institutional investors have bought a total of 4,078,000 shares in the last 24 months. This purchase volume represents approximately $1.52M in transactions. Related Companies MURA Major Shareholders CDTX Major Shareholders RPHM Major Shareholders KRON Major Shareholders DTIL Major Shareholders IMRX Major Shareholders CVM Major Shareholders BRNS Major Shareholders THTX Major Shareholders ATNM Major Shareholders This page (NYSE:AIM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.